At the forefront of innovation 

In BIOCAPAN we aim at developing an innovative treatment for Diabetes Mellitus, based on the implantation of smartly microencapsulated allogeneic islet cells, which will allow an effective long-lasting blood glucose normalization and stabilisation, without the need for immunosuppressants.

The company´s main contribution is related to validation, nanosafety characterization and standardization (in vitro and in vivo) of the use of new biomaterials and nanomatrices for nanoencapsulation of pancreatic islets.

http://www.biocapan.eu/